再谈通用名药物替换 - Suppr

Suppr

超能文献

Generic drug substitution revisited.

作者信息

Strom B L

出版信息

N Engl J Med. 1987 Jun 4;316(23):1456-62. doi: 10.1056/NEJM198706043162306.

DOI:10.1056/NEJM198706043162306

PMID:3553952

Abstract

摘要

相似文献

Generic drug substitution revisited.再谈通用名药物替换

N Engl J Med. 1987 Jun 4;316(23):1456-62. doi: 10.1056/NEJM198706043162306.

Substituting generic drugs: state roles.替换通用药物：国家的作用。

NCSL Legisbrief. 2009 Jun-Jul;17(25):1-2.

Benefits and liabilities of generic prescribing.通用处方的益处与弊端。

W V Med J. 1972 Jun;68(6):161-6.

Generic vs. brand name drugs--defining and enforcing standards.

Internist. 1979 May;20(4):11, 13.

Lawsuits anticipated on generic biologicals front.预计在生物仿制药领域会有诉讼。

Nat Biotechnol. 2003 Jul;21(7):721-2. doi: 10.1038/nbt0703-721.

Doctors are pivotal to prescription struggle.

Leg Aspects Med Pract. 1979 Mar;7(3):42-4.

Pharmaceuticals: generic/ therapeutic drug substitution: year end report-2002.药品：通用名/治疗性药物替换：2002年年终报告

Issue Brief Health Policy Track Serv. 2002 Dec 31:1-12.

New York's generic drug substitution law.

N Y State Dent J. 1980 Nov;46(9):599-604.

Comment: Pharmacy and generic substitution of antiepileptic drugs: missing in action?评论：抗癫痫药物的药学及非专利药品替换：付诸阙如？

Ann Pharmacother. 2007 Sep;41(9):1550-1; author reply 1551-2. doi: 10.1345/aph.1K076a. Epub 2007 Jul 24.

Pharmaceuticals issue brief: generic and therapeutic substitution: year end report--2004.药品问题简报：非专利药与治疗性替代：2004年年终报告

Issue Brief Health Policy Track Serv. 2004 Dec 31:1-14.

引用本文的文献

Brand generic: addressing non-adherence, secular trends and non-overlap.品牌药与仿制药：解决不依从性、长期趋势及非重叠问题

J R Stat Soc Ser A Stat Soc. 2020 Oct;183(4):1461-1478. doi: 10.1111/rssa.12573. Epub 2020 May 20.

Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study.韩国精神分裂症患者中品牌名与通用名氯氮平长期维持治疗的疗效及副作用比较研究：一项回顾性自然对照镜像研究

Psychiatry Investig. 2024 Mar;21(3):311-320. doi: 10.30773/pi.2023.0413. Epub 2024 Mar 25.

The use of GA-RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations-based model) method to optimize bioequivalence studies.利用 GA-RxODE（基于遗传算法和常微分方程运行模拟的方法）优化生物等效性研究。

Pharmacol Res Perspect. 2021 Oct;9(5):e00824. doi: 10.1002/prp2.824.

Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan.品牌抗抑郁药在预防抑郁症住院方面优于其仿制药：来自中国台湾的真实世界证据。

Int J Neuropsychopharmacol. 2020 Dec 10;23(10):653-661. doi: 10.1093/ijnp/pyaa041.

Transplant coordinators' perceived impact of availability of multiple generic immunosuppression therapies on patients, workload, and posttransplant maintenance therapy.移植协调员对多种通用免疫抑制疗法的可及性对患者、工作量及移植后维持治疗的感知影响。

J Transplant. 2013;2013:897434. doi: 10.1155/2013/897434. Epub 2013 Jan 8.

Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.在中性粒细胞减少症小鼠大腿感染模型中测定庆大霉素仿制药的治疗等效性。

PLoS One. 2010 May 20;5(5):e10744. doi: 10.1371/journal.pone.0010744.

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.使用通用名与品牌名抗癫痫药物的癫痫发作结局：系统评价和荟萃分析。

Drugs. 2010 Mar 26;70(5):605-21. doi: 10.2165/10898530-000000000-00000.

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.心血管疾病中使用的仿制药和品牌药的临床等效性：一项系统评价和荟萃分析。

JAMA. 2008 Dec 3;300(21):2514-26. doi: 10.1001/jama.2008.758.

Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.处方药的参考定价：探索血管紧张素转换酶抑制剂的等效性。

CMAJ. 1999 Aug 10;161(3):255-60.

Bioinequivalence and drug toxicity. How great is the problem and what can be done?生物不等效性与药物毒性。问题有多严重，又能采取什么措施？

Drug Saf. 1994 Jul;11(1):1-6. doi: 10.2165/00002018-199411010-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验